Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
Brief Summary: The purpose of this study is to find a dose of intravitreal bevacizumab that is lower than currently used for severe retinopathy of prematurity (ROP), is effective in this study, and can be tested in future larger studies.